Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impact.

Publication date: Jan 27, 2024

Nucleobases serve as essential molecular frameworks present in both natural and synthetic compounds that exhibit notable antiviral activity. Through molecular modifications, novel nucleobase-containing drugs (NCDs) have been developed, exhibiting enhanced antiviral activity against a wide range of viruses, including the recently emerged SARS-CoV-2. This article provides a detailed examination of the significant advancements in NCDs from 2015 till current, encompassing various aspects concerning their mechanisms of action, pharmacology and antiviral properties. Additionally, the article discusses antiviral prodrugs relevant to the scope of this review. It fills in the knowledge gap by examining the structure-activity relationship and trend of NCDs as therapeutics against a diverse range of viral diseases, either as approved drugs, clinical candidates or as early-stage development prospects. Moreover, the article highlights on the status of this field of study and addresses the prevailing limitations encountered.

Concepts Keywords
Future Analogue
Molecular Antiviral
Revolutionary Nucleobase
Therapeutics Nucleoside
Viruses Nucleotide
Structure-activity relationship


Type Source Name
disease VO Viruses
disease VO Gap
disease MESH viral diseases

Original Article

(Visited 1 times, 1 visits today)